Selective glycosidase inhibitors and uses thereof
US9815861B2 · kind B2 · utility
0Cited by
15References
23Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Dec 11, 2015 |
| Grant date | Nov 14, 2017 |
| Priority date | — |
| Expiry date | Dec 11, 2035 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2500/20
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention provides compounds with enhanced permeability for selectively inhibiting glycosidases, prodrugs of the compounds, and pharmaceutical compositions including the compounds or prodrugs of the compounds. The invention also provides methods of treating diseases and disorders related to deficiency or overexpression of O-GlcNAcase, accumulation or deficiency of O-GlcNAc.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.